ASMB R&D Day: Scientific rationale for being able to eradicate HBV cccDNA with company’s core inhibitors is based on retrospective half-life analysis of decade-old patient samples.
Caveat emptor.
Thanks for posting. Sorry, I've been away several days and just now getting up to speed and still haven't had a chance to listen to this yet (should get to it this weekend). It looks like the webcast is nearly 3 hours long. Did you listen to the whole thing?